https://doi.org/10.22037/ijpr.2018.2251

Evaluation of Chemical Composition and In-vitro Biological Activities of Three Endemic Hypericum Species from Anatolia (H. thymbrifolium, H. spectabile and H. pseudolaeve)

authors:

avatar Esra Eroglu Ozkan a , * , avatar Nurten Ozsoy b , avatar Tugba Yilmaz Ozden b , avatar Gul Ozhan c , avatar Afife Mat a

Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Department of Biochemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Iranian Journal of Pharmaceutical Research : IJPR: Vol.17, issue 3; 1036-1046
article type: Original Article
received: January , 2016
accepted: December , 2016

How To Cite Ozkan E E, Ozsoy N, Ozden T Y, Ozhan G, Mat A. Evaluation of Chemical Composition and In-vitro Biological Activities of Three Endemic Hypericum Species from Anatolia (H. thymbrifolium, H. spectabile and H. pseudolaeve). Iran J Pharm Res. 2018;17(3):e124777. https://doi.org/10.22037/ijpr.2018.2251.

Abstract

In the present work we carried out a phytochemical and biological investigation on three endemic Hypericum species, i.e.Hypericum thymbrifolium (H. thymbrifolium), Hypericum spectabile (H. spectabile) and Hypericum pseudolaeve (H. pseudolaeve) from Anatolia in order to discover new sources of natural compounds for the treatment of inflammatory and neurodegenerative disorders. HPLC-DAD analysis indicated that two naphthodianthrones (pseudohypericin and hypericin) together with chlorogenic acid, rutin, hyperoside, isoquercitrin, kaempferol, quercitrin, quercetin, amentoflavone, and hyperforin are the main compounds present in the methanol extracts. After chemical characterization, all extracts were in-vitro biologically assayed for antioxidant potential by lipid peroxidation inhibitory activity, DPPH, FRAP assays, and superoxide radical scavenging activity, for AChE inhibitory activity by Ellman’s method, for COX inhibitory activity by using enzyme immunoassay (EIA) kit, for cytotoxic activity on HeLa and NRK-52E cell lines by MTT assay. The superoxide radical scavenging activity and lipid peroxidation inhibitory activity of H. spectabile (EC50 = 0.430 mg/mL) were more remarkable than that of H. thymbrifolium and H. pseudolaeve. The extracts showed moderate inhibitory activity on AChE (from 49.37% to 63.41%). The best inhibitory activity against COX-1 (71.77% and 77.04%, respectively) and COX-2 ( 64.14% and 72.23%, respectively) were shown by H. thymbrifolium and H. spectabile, which may be due to their richest chlorogenic acid content (0.29576% and 0.23567%, respectively). Cytotoxicity screening results showed that the extracts did not demonstrate significant cytotoxic activity. It was concluded that the most promising extract with antioxidant, anti-inflammatory, and AChE inhibition potential is H. spectabile.

Introduction

The genus Hypericum L. (Hypericaceae) has been used for centuries for the treatment of burns, bruises, swelling, inflammation, and anxiety, as well as bacterial and viral infections. Locally, it is traditionally used both externally (as a cream or oil extract) and internally (as a tea) with many therapeutic applications (1-4). Hypericum has nearly 465 species all over the world and is represented by nearly 100 taxa grouped under 19 sections in Turkey, among them, 45 taxa are endemic (5-7).

For the last few years, there has been an increasing biological activity trend and awareness in Hypericum research. Quite a significant amount of research has already been carried out in exploring the chemistry of different parts of Hypericum (8-15). The pharmacological studies showed that this species have several activities, namely, antidepressant, anti-inflammatory, antimicrobial, antiviral, antinociceptive, and wound healing (5). In the recent years, anti-depressant applications of Hypericum medical products have become increasingly popular (16). The antidepressant activity was first attributed to hypericins (naphthodianthrone derivatives), but recent pharmacological and clinical results focus on hyperforins (phloroglucinol derivatives) as the main active ingredients of the extract. Hypericum perforatum L. (St. John’s wort) preparative forms have recently gained popularity as an alternative treatment for mild to moderate depression (17). It is heartening to see that a traditional plant medicine has now led to several therapeutically useful preparations, which encourage the scientists to explore more information about this medicinal plant. It has been reported that Hypericum species contain variety of phenolic compounds and represent good sources of antioxidants which increase their usability potential in ethnomedicine (9, 13). Numerous antioxidant investigations have been carried out on Hypericum species (18-26).

It has been reported that Hypericum species have anti-inflammatory activity in-vitro and in different animal models of edema possibly due to inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression (27, 28). COX-2 is responsible for the production of pro-inflammatory mediators, prostaglandins, at the inflammatory site (29). Recognition of COX-2’s key role in inflammation led to the hypothesis that it may represent a primary target for non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer’s disease (AD), consistent with inflammatory processes occurring in AD brain (30).

Cholinesterase inhibitors are the first-line treatment for AD. Acetylcholinesterase (AChE) inhibitory potential of some Hypericum species has been reported in previous studies (31-35).

Analysis of the cytotoxicity and anticancer cell proliferation activity was conducted in a variety of Hypericum species (36). It was reported that H. perforatum has no cytotoxic potential and oral consumption by humans is safe (37).

Considering the important role of oxidative stress and inflammation in the pathogenesis of neurological diseases such as AD, and the growing evidence of the presence of compounds with antioxidant, anti-inflammatory and AChE inhibitory potential in different Hypericum species; the aim of the present study was to investigate the chemical profiles and antioxidant, anti-inflammatory, anti-AChE and cytotoxic potential of the extracts from three endemic Hypericum species (Hypericum thymbrifolium Boiss. and Noë, Hypericum spectabile Jaub. and Spach., Hypericum pseudolaeve Robson) of the Turkish flora. Our research is the first report to study the phytochemical profiles and biological activities in these species.

Experimental

Chemical agents

Hypericin, chlorogenic acid, rutin, hyperoside, isoquercitrin, quercitrin, kaempferol, quercetin, amentoflavon, hyperforin, AlCl3, and D-galactose were obtained from Sigma-Aldrich (Taufkirchen, Germany). Pseudohypericin was obtained from PhytoPlan (Heidelberg, Germany). Milli-Q ultrapure water was obtained from Millipore (Billerica, MA, USA), HPLC grade acetonitrile, methanol, ethyl acetate and sodium dihydrogen phosphate dihydrate were obtained from Merck (Darmstadt, Germany) and ortho-phosphoric acid 85% was obtained from Fluka (Buchs, Switzerland).

Nitroblue tetrazolium (NBT), β-nicotinamide adenine dinucleotide reduced (β-NADH), soybean L-α-phosphatidylcholine type IV-S, quercetin and catechin were purchased from Fluka (Buchs, Switzerland). Phenazine methosulphate (PMS), 2,2-diphenyl-1-picryl-hydrazyl (DPPH), gallic acid, ascorbic acid, 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB), acetylthiocholine iodide (ATChI), AChE, galantamine hydrobromide were obtained from Sigma-Aldrich (St. Louis, MO, USA). 2,4,6-tripyridyl-s-triazine (TPTZ), trichloroacetic acid (TCA), thiobarbituric acid (TBA) and ferric chloride were obtained from Merck (Darmstadt, Germany). Enzyme immunoassay (EIA) kit and aspirin were obtained from Cayman Chemical (Ann Arbor, MI, USA).

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reagent was purchased from Sigma (St. Louis, MO, USA). Dimethylsulfoxide (DMSO), trypsin was purchased from (Biomatik, Canada). Ethylenediamine tetra acetic acid (EDTA), sodium hydroxide was purchased from Merck (Darmstadt, Germany). Fetal bovine serum (FBS), Dulbecco’s Modified Eagle Medium (DMEM), penicillin-streptomycin, phosphate buffer saline (PBS) were purchased from Multicell-Wisent Inc. (Quebec, Canada). Cytotoxicity detection kit (LDH) which containing catalyst, dye solution and stop solution were purchased from Roche (Mannheim, Germany). All other reagents were of analytical grade.

Plant material

During the field investigations conducted in June 2010, specimens of flowering aerial parts of H. thymbrifolium, H. spectabile and H. pseudolaeve were gathered from their natural habitats on the roadsides nearby the town of Malatya located in the East Anatolia Reagion of Turkey: H. thymbrifolium (Malatya: Malatya to Darende, 10 km to Gürün, 1425 m), H. spectabile: (Malatya: Arapgir to Kemaliye, 40 km to Kemaliye, 1157 m) and H. pseudolaeve (Malatya: Malatya to Arapgir, 20 km to Arapgir, 1264 m). The plant materials were identified by Prof. Dr. Şükran Kültür and voucher specimens were deposited in the Herbarium of the Istanbul University Faculty of Pharmacy, Istanbul, Turkey (ISTE 93194, 93192 and 93193, respectively).

Preparation of the extracts

The samples were air-dried at room temperature under shade. The dried flowering aerial parts (10 g) of the species were macerated in methanol (100 mL) for 3 days at room temperature at dark and the resulting extract was filtered through Whatman No-1. The residue from the filtration was extracted again twice using the same procedure. The filtrates were combined and then evaporated to dryness under reduced pressure at a temperature below 45 °C. The crude methanol extract was lyophilized and stored at -20 °C (38, 39). The extracts prepared with this procedure were used in the HPLC analysis and biological activity studies.

HPLC analysis

Preparation of the standards

The calibration curves were prepared with analytical standards at the different concentration in methanol. The experiment was conducted three times providing the same conditions. The calibration curves were constructed by using average of peak areas and at least five different standard concentrations.

Preparation of the samples

The crude methanol extract was dissolved in mixture of methanol/water (8:2, v/v) (40). All samples were filtered through a 0.45 µm filter into a vial for HPLC analysis. Each sample was prepared and injected three times.

Chromatographic HPLC conditions

The Hypericum species have been analyzed by reversed phase HPLC coupled with DAD (HPLC-DAD). The HPLC system consisted of a Shimadzu 10A model (DAD: SPD-M10A), pump: LC-10AD and an autosampler: SIL-10AD.

The separation was accomplished on an ACE C18 (250 × 4.6 mm, particle size 5 µm) (Advanced Chromatography Technologies, Alberdeen, Scotland) column. The elution conditions were as follows: flow rate: 1 mL/min; column temperature: 40 °C; injection volume: 10 µL; detection: 590 nm for pseudohypericin and hypericin, 360 nm for phenolic compounds and 275 nm for hyperforin.

The solvent system was used as an isocratic to identify and quantitate pseudohypericin and hypericin. Separation was carried out using solvent A [ethyl acetate/15.6 g/L sodium dihydrogen phosphate adjusted to pH 2 with phosphoric acid/methanol (39:41:160, v/v/v)]. The solvent system was used as a gradient to identify and quantitate phenolic compounds and hyperforin. The mobile phase consisted of solvent A (0.3% formic acid in water (v/v) and solvent B (0.3% formic acid in acetonitrile (v/v). The following gradient was applied: 0-8 min, 82% A; 8-18 min, 82-47% A; 18-18.1 min, 47-3% A; 18.1-29 min, 3% A; 29-40 min, 3-82% A (European Pharmacopoeia, 2008). All solvents were filtered through a 0.45 µm filter prior to use and degassed in an ultrasonic bath.

The control of the system and the data analysis procedure were performed with Shimadzu LC Solutions software.

Table 1

Chemical compounds of methanolic extracts of Hypericum species

CompoundsRetention time (min)Calibration equation valuesLinear regression (r2)H. spectabile(yield%)H. pseudolaeve(yield%)H. thymbrifolium (yield%)
Pseudohypericin4.86y = 2.582269e + 007x + 1741.8740.99980.0015 ± 0.00020.0131 ± 0.00040.0088 ± 0.0007
Hypericin13.93y = 6.03411e + 007x + 297.22920.99990.0070 ± 0.00010.0038 ± 0.00010.0044 ± 0.0001
Chlorogenic acid4.33y = 5110294x + 1490.3980.99990.2357 ± 0.02690.3223 ± 0.09390.2957 ± 0.0603
Rutin8.89y = 1.383368e + 007x + 5188.1820.99990.0083 ± 0.00040.1208 ± 0.00110.0100 ± 0.0006
Hyperoside10.19y = 2.849917e + 007x + 526.70230.99990.1138 ± 0.00650.2066 ± 0.06520.1681 ± 0.0381
Isoquercitrin10.75y = 1.671137e + 007x – 3712.7880.99990.1387 ± 0.01260.1869 ± 0.02770.3038 ± 0.0661
Quercitrin14.41y = 1.205178e + 007 – 3518.9740.99991.2863 ± 0.05540.2610 ± 0.03840.1553 ± 0.0121
Kaempferol17.09y = 5.183916e + 007x + 4373.8560.99990.0081 ± 0.00080.0036 ± 0.00040.0007 ± 0.00003
Quercetin17.84y = 3.688175e + 007x + 18905.430.99990.0567 ± 0.00650.0592 ± 0.00520.0388 ± 0.0013
Amentoflavon20.27y = 2.207879e + 007x + 772.09720.99960.0030 ± 0.00010.0032 ± 0.00010.0027 ± 0.0001
Hyperforin27.75y = 6212343x0.99970.0041 ± 0.00020.0023 ± 0.0002Nd

Values were the means of three replicates standard deviation, Nd: not dete.

Table 2

Total extractable compounds (EC), total phenolic compounds (PC) (as gallic acid equivalents) and total flavonoids (as catechin equivalents) in the extracts

ExtractsEC(mg/g DW)PC(mg/g DW)Flavonoid(mg/g DW)PC/EC (%)
H. thymbrifolium172.320.7 2.1a16.9 0.51a10.4
H. spectabile213.523.1 2.37a22.4 0.34b10.8
H. pseudolaeve149.113.3 1.70b10.3 0.23c8.9
Table 3

Antioxidant activities (EC50 values), AChE inhibitory and anti-inflammatory activities of the extracts

ExtractsEC50 (mg/mL)A
FRAP valueB*(mM Fe 2+ )AChE* Inhibition(% )COX-1* Inhibition (%)COX-2* Inhibition (%)
Anti-LPODPPHSuperoxide
H. thymbrifolium4.39 0.08a0.622 0.051a0.641 0.069a2.58 0.036a63.41 ± 3.29a71.77 2.93a64.14 2.32a
H. spectabile2.80 0.28b0.567 0.028a0.430 0.006b2.66 0.031a59.49 ± 3.14a77.04 1.55a72.23 5.41a
H. pseudolaeve5.41 0.55a0.916 0.036b1.730 0.060c2.21 0.015b49.37 ± 3.48b43.27 5.44b52.66 3.03b
Quercetin0.06 0.001c0.034 0.001c0.513 0.013a, b2.84 0.01a, γ
Galantamine89.86 0.34c, δ
Aspirin73.53 3.57a, ε

EC50 value: The effective concentration at which the antioxidant activity was 50%; DPPH and superoxide radicals were scavenged by 50%;

Expressed as mM ferrous ions eqivalents.

Determined at 5 mg/mL.

Determined at 1.25 mg/mL.

Determined at 0.05 mg/mL.

Determined at 0.5 mg/mL.

Table 4

Cytotoxic potential of the extracts

ExtractsIC50 values (mg/mL)
HeLaNRK-52E
H. thymbrifoliumNaNa
H. spectabileNaNa
H. pseudolaeve1.2180.964

Determination of total phenolic compounds

Total soluble phenolics in the methanolic extracts were determined with Folin-Ciocalteu reagent according to the method of Slinkard and Singleton with some modifications (41). The amount of total phenolic compounds was calculated from the calibration curve of gallic acid standard solution (covering the concentration range between 0.05 and 0.4 mg/mL) and expressed as mg gallic acid equivalents (GAE)/g dry weight (DW) of the plant material.

Determination of total flavonoid content

Total flavonoid content was determined by using a method described by Sakanaka et al. (2005). Total flavonoid contents were calculated from the calibration curve prepared with catechin standard solution and expressed mg of (+)-catechin equivalents (CE) per g of DW of the plant material.

Determination of antioxidant activity

Quercetin was used as reference antioxidant for the antioxidant activity assays.

Inhibition of lipid peroxidation (LPO)

LPO assay was based on the method described by Duh et al. (42). The formation of LPO products was assayed by the measurement of malondialdehyde (MDA) levels on the basis of MDA reacted with TBA at 532 nm according to Buege and Aust (43). The percentage inhibition of LPO was calculated by comparing the results of the sample with those of controls not treated with the extract using the following Equation:

Inhibition effect (%) = (1 − absorbance of sample at 532 nm/absorbance of control at 532 nm) × 100.

DPPH radical scavenging activity

The DPPH radical scavenging activity of the methanolic extracts was measured according to the procedure described by Brand-Williams et al. (44). The ability to scavenge DPPH radical was calculated by the following Equation:

DPPH radical scavenging activity (%) = (1 − absorbance of sample at 517 nm/absorbance of control at 517 nm) × 100.

Superoxide radical scavenging activity

The effects of the methanolic extracts on generation of superoxide radicals were determined by the NBT reduction method (45). The abilities to scavenge the superoxide radical were calculated by comparing the results of the sample with those of controls not treated with the extract using the following Equation:

Superoxide radical scavenging activity (%) = (1 − absorbance of sample at 560 nm/absorbance of control at 560 nm) × 100.

Ferric reducing antioxidant power (FRAP) assay

The FRAP assay was carried out according to the procedure of Benzie and Strain (46). The standard curve was constructed using iron sulphate heptahydrate solution (125-2000 µM), and the results were expressed as mM Fe2+ equivalents.

Determination of AChE inhibitory activity

The extracts were screened for their AChE inhibitory activity through the modified Ellman›s spectrophotometric method (47). Galantamine hydrobromide was used as a standard and tested in a concentration range between 12.5 to 100 µg/mL (33.75 to 270 µM). Any increase in absorbance due to the spontaneous hydrolysis of substrate was corrected by subtracting the rate of the reaction before adding the enzyme from the rate after adding the enzyme.

AChE Inhibition (%) = (1 – reaction rate of sample at 412 nm/reaction rate of negative control at 412 nm) × 100.

Determination of COX inhibitory activity

The ability of the extracts to inhibit ovine COX-1 and COX-2 was determined by calculating percent inhibition of prostaglandin production using EIA kit (Catalogue No. 560101, Cayman Chemical) according to the manufacturer›s instructions. Aspirin was used as a standard.

In-vitro cytotoxic activity

Cytotoxicity of Hypericum species at various concentrations was determined on human cervix adenocarcinoma (HeLa, ATCC® CCL-2™) and normal rat kidney epithelial (NRK-52E, ATCC® CRL-6509™) cell lines by the MTT assay, which is widely used for the measurement of cell viability (48, 49). Briefly, the cells were seeded in 96-well plates at a density of 104 cells/well in 100 μL culture medium. Following 24-h incubation and attachment, the cells were treated with different concentrations of plant extracts and controls for 24 h. Dry methanolic extracts were dissolved in DMSO as a solvent to obtain appropriate stock solutions of the extracts. Dilution of stock extracts solutions was made in serum free medium yielding final extracts concentrations from 0.125 to 2 mg/mL. DMSO and 5-fluorouracil (5-FU) were used solvent and positive controls, respectively (32, 50). The concentration range used for 5-FU was 50 to 1000 μM. The yellow MTT dye was reduced by succinic dehydrogenase in the mitochondria of viable cells to purple formazan crystals. The absorbance was measured by a microplate reader (BioTek, USA) at 570 nm with a reference wavelength of 670 nm. The reduction of absorbance was evaluated the inhibition of enzyme activity observed in cells compared to untreated (negative control) cells. Then, the half maximal inhibitory concentration (IC50) was expressed as the concentration of sample caused an inhibition of 50% in enzyme activities in cells as flows (48, 49). IC50 was calculated by using following Equation:

IC50 (%) = 100 - [mean absorbance of extract × 100)/mean absorbance of solvent control]

The results were generated from three independent experiments; each experiment was performed in triplicate.

Statistical analysis

Results were expressed as mean ± standard deviation. Statistical comparisons were performed with Student’s t-test. Differences were considered significant at p < 0.05.

Results and Discussion

HPLC analysis

Table 1 shows the main components of the extracts of Hypericum species analyzed by HPLC and retention times, the equations and r2 values obtained from calibration curves.

H. thymbrifolium, H. spectabile and H. pseudolaeve were enriched with chlorogenic acid. Our results are in an agreement with those reported in former studies in that the most common flavonoids present in Hypericum species under study are rutin, hyperoside, isoquercitrin, quercitrin, and quercetin (8, 10, 12-15).

Phytochemical composition of Hypericum species has been reported in various research works. The main compounds that gave a significant antioxidant activity from the ethanolic extract of H. perforatum were identified to be rutin and isoquercitrin as determined by HPLC, mass spectrometry, UV/Vis spectroscopy, and TLC (22, 23 and 51).

Total phenolic and flavonoid compounds

The yields, total phenolics and flavonoids of methanolic extracts obtained from aerial parts of Hypericum species are shown in Table 2. The amount of extractable compounds ranged from 149.1 to 213.5 mg/g DW. Among the three extracts, H. spectabile and H. thymbrifolium contained the highest amount of extractable compounds while the extract of H. pseudolaeve contained the lowest one.

The content of total phenols in extracts, ranged between 13.3 ± 1.70 and 23.1 ± 2.37 mg GAE/g DW. No significant differences (p > 0.05) were found between the amount of total phenolic compounds in H. thymbrifolium and H. spectabile, while the amount of phenolics in H. pseudolaeve were the lowest (p < 0.05). Our results were consistent with the previous observation on the total phenolic content of some Hypericum species (24, 25 and 52). The flavonoid contents varied from 10.3 ± 0.23 to 22.4 ± 0.34 mg CE/g DW which is in accordance with the previously published data (53). The amount of flavonoids in H. spectabile, was higher than that of H.thymbrifolium and H. pseudolaeve.

Antioxidant activity

In the present study we evaluated the antioxidant activity of Hypericum species, measuring their ability of inhibiting LPO, reducing power, and radical scavenging activities. For comparison, Table 3 presents the results of the antioxidant activities, expressed as half maximal effective concentration (EC50) and FRAP values.

All the extracts demonstrated the ability to inhibit LPO, which is in accordance with the previously published data for Hypericum species (22, 23, 25, 52, 54 and 55). The anti-LPO activities of H. thymbrifolium and H. pseudolaeve extracts were comparable (p > 0.05) and less effective than that of H. spectabile. However, none of the extracts were as effective LPO inhibitor as the reference antioxidant quercetin (0.06 ± 0.001 mg/mL).

H. thymbrifolium and H. spectabile did not differ in their DPPH radical scavenging activities (p > 0.05), which were higher than that of H. pseudolaeve. Our results were consistent with the previous observation that Hypericum species contain radical-scavenging agents that could directly react with and quench stable DPPH radicals (22, 25 and 55). Nonetheless, when compared to the the EC50 value obtained for the quercetin (0.034 ± 0.001 mg/mL), the DPPH scavenging activities of the extracts were found to be significantly lower (p < 0.05).

The superoxide radical scavenging activities of H. thymbrifolium and H. spectabile were comparable to that of quercetin (0.513 ± 0.013 mg/mL). In accordance with Hunt et al. observations, the results implied that Hypericum extracts are superoxide scavengers and their capacity to scavenge superoxide may contribute to their antioxidant activity (18).

In the FRAP assay, on the basis of the standard (Fe2+), it was found that the extracts possess high reducing power (the range between 2.21 and 2.66 mM Fe2+) at 5 mg/mL concentration. It was comparable (p > 0.05) to that of quercetin (2.84 ± 0.01 mM Fe2+) at 1.25 mg/mL (Table 3). This observation was in an agreement with other reports (25, 53 and 55).

Our results showed that H. spectabile had a highest degree of potency in inhibiting LPO, demonstrated strongest reducing power and scavenging activity against the DPPH and superoxide radicals, indicating the highest antioxidant potential amongst the three extract under study. H. thymbrifolium demonstrated similar ability to that of H. spectabile to reduce ferric (III) iron to ferrous (II) iron and scavenge DPPH radical (p > 0.05) but was less effective LPO inhibitor together with H. pseudolaeve. The least effective antioxidant was H. pseudolaeve.

These findings were in agreement with our observation on phenolic contents of the extracts and seemed to suggest phenolics to be important contributors to the antioxidant activity. This result was in agreement with previous reports that the phenolic compounds contribute significantly to the antioxidant activity in different Hypericum species (19, 21-23, 40, 51, 53 and 56).

AChE inhibitory activity

Hypericum extracts were tested for their in-vitro AChE inhibitory activities using galantamine as a positive control. The results, expressed as percentage inhibitions, are summarized in Table 3.

The extracts exhibited moderate AChE inhibitory activities (49.37- 63.41%) at 5 mg/mL concentration. However, no plant extracts could have greater inhibitory ability than the positive control galantamine (89.86 ± 0.34%) at a concentration of 0.05 mg/mL (135 µM). Similar results were reported for H. undulatum by Ferreira et al. (57). Wszelaki et al. reported the lower (28%) AChE inhibition by methanolic extract of H. perforatum at a concentration of 400 µg/mL (33).

Anti-inflammatory activity

Methanol extracts of the aerial parts of Hypericum species under study were tested for their anti-inflammatory activity in comparison with aspirin used as the positive control. The ability of the extracts to inhibit COX-1 and COX-2 was determined by calculating percent inhibition of prostaglandin production (Table 3). It was found that all examined extracts exhibited inhibiting power against COX-1 and COX-2. The greatest anti-inflammatory effect was observed for H. thymbrifolium and H. spectabile. It was comparable to that of aspirin (73.5 ± 3.5%) at a concentration of 500 µg/mL.

Because of published evidence that flavonoids possess anti-inflammatory activity, the extract with the highest concentrations of flavonoids was expected to be the most anti-inflammatory (58). It can be explained with the different phytochemical composition of the extracts. H. spectabile, H. thymbrifolium and H. pseudolaeve extracts contained higher amount of chlorogenic acid. It was reported that chlorogenic acid contributed significantly to the anti-inflammatory activity of the Hypericum species (59). Chlorogenic acid represents a promising potential drug of natural anti-inflammatory property for the development of new drugs that may help to control oxidative stress and consequently the inflammatory response (60-62).

In-vitro cytotoxic activity

Hypericum species extracts were evaluated for their cytotoxic activities in HeLa and NRK-52E cell lines.

The extracts did not demonstrate significant cytotoxic activity against both HeLa and NRK-52E cell lines (IC50 ≤ 1.218) (Table 4). Also, the responses of two cells to 5-FU were showed in Table 4. Our results were consistent with the previous observation that Hypericum species did not show significant cytotoxic activity against some tumor cell lines (23, 36, 37, 40, 63 and

64).

Conclusion

HPLC results showed that Hypericum species from Anatolia represent a good source of phenolic compounds. In particular, H. spectabile resulted endowed with high levels of quercitrin which may support its biological activities. In addition to this, the high content of quercitrin has a well known anti-inflammatory effect. As a conclusion, these results induce to further investigate the biological properties of H. spectabile.

Acknowledgements

References

  • 1.

    Sezik E, Yeşilada E, Honda G, Takaishi Y, Takeda Y, Tanaka T. Traditional medicine in Turkey X Folk medicine in central Anatolia. J. Ethnopharmacol. 2001;75:95-115. [PubMed ID: 11297840].

  • 2.

    Honda G, Yeşilada E, Tabata M, Sezik E, Fujita T, Takeda Y, Takaishi Y, Tanaka T. Traditional medicine in Turkey VI Folk medicine in West Anatolia: Afyon, Kütahya, Denizli, Muğla, Aydin provinces. J. Ethnopharmacol. 1996;53:75-87. [PubMed ID: 8844462].

  • 3.

    Kültür Ş. Medicinal plants used in Kırklareli province (Turkey). J. Ethnopharmacol. 2007;111:341-64. [PubMed ID: 17257791].

  • 4.

    Tala MF, Tchakam PD, Wabo HK, Talontsi FM, Tane P, Kuiate JR, Tapondjou LA, Laatsch H. Chemical constituents, antimicrobial and cytotoxic activities of Hypericum riparium (Guttiferae). Rec. Nat. Prod. 2013;7:65.

  • 5.

    Muller WE. Current St John’s wort research from mode of action to clinical efficacy. Pharmacol. Res. 2003;47:101-9. [PubMed ID: 12543057].

  • 6.

    Özkan EE, Özsoy N, Özhan G, Celik BÖ, Mat A. Chemical composition and biological activities of Hypericum pamphylicum. Ind. Crops Prod. 2013;50:182-9.

  • 7.

    Muller WE. St. John’s wort and its active principles in deppression and anxiety. Basel, Switzerland: Birkhäuser Verlag; 2005.

  • 8.

    Cirak C. Hypericin in Hypericum lydium Boiss growing in Turkey. Biochem. Syst. Ecol. 2006;34:897-9.

  • 9.

    Smelcerovic A, Spiteller M, Ligon AP, Smelcerovic Z, Raabe N. Essential oil composition of Hypericum L species from Southeastern Serbia and their chemotaxonomy. Biochem. Syst. Ecol. 2007;35:99-113.

  • 10.

    Smelcerovic A, Zuehlke S, Spiteller M, Raabe N, Ozen T. Phenolic constituents of 17 Hypericum species from Turkey. Biochem. Syst. Ecol. 2008;36:316-9.

  • 11.

    Ayan AK, Cirak C. Hypericin and pseudohypericin contents in some Hypericum species growing in Turkey. Pharm. Biol. 2008;46:288-91.

  • 12.

    Cirak C, Radusiene J, Camas N. Pseudohypericin and hyperforin in two Turkish Hypericum species: Variation among plant parts and phenological stages. Biochem. Syst. Ecol. 2008;36:377-82.

  • 13.

    Cirak C, Radusiene J, Janulis V, Ivanauskas L, Camas N, Ayan AK. Phenolic constituents of Hypericum triquetrifolium Turra (Guttiferae) growing in Turkey: Variation among populations and plant parts. Turk. J. Biol. 2011;35:449-56.

  • 14.

    Cirak C, Radusiene J, Camas N, Caliskan O, Odabas MS. Changes in the contents of main secondary metabolites in two Turkish Hypericum species during plant development. Pharm. Biol. 2013;51:391-9. [PubMed ID: 23406360].

  • 15.

    Camas N, Radusiene J, Ivanauskas L, Jakstas V, Kayikci S, Cirak C. Chemical composition of Hypericum species from the Taeniocarpium and Drosanthe sections. Plant Syst. Evol. 2014;300:953-60.

  • 16.

    Demirkiran O, Mesaik MA, Beynek H, Abbaskhan A, Choudhary MI. Immunosupressive Phenolic Constituents from Hypericum montbretii Spach. Rec. Nat. Prod. 2013;7:210-9.

  • 17.

    Greeson JM, Sanford B, Monti DA. St John’s wort (Hypericum perforatum): A review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology. 2001;153:402-14. [PubMed ID: 11243487].

  • 18.

    Hunt EJ, Lester CE, Lester EA, Tackett RL. Effect of St John’s wort on free radical production. Life Sci. 2001;69:181-90. [PubMed ID: 11441908].

  • 19.

    Conforti F, Statti GA, Tundis R, Bianchi A, Agrimonti C, Sacchetti G, Andreotti E, Menichini F, Poli F. Comparative chemical composition and variability of biological activity of methanolic extracts from Hypericum perforatum L. Nat. Prod. Res. 2005;19:295-303. [PubMed ID: 15702645].

  • 20.

    Conforti F, Statti GA, Tundis R, Menichini F, Houghton P. Antioxidant activity of methanolic extract of Hypericum triquetrifolium Turra aerial part. Fitoterapia. 2002;73:479-83. [PubMed ID: 12385870].

  • 21.

    Valentao P, Fernandes E, Carvalho F, Andrade PB, Seabra RM, Bastos MD. Antioxidant activity of Hypericum androsaemum infusion: Scavenging activity against superoxide radical, hydroxyl radical and hypochlorous acid. Biol. Pharm. Bull. 2002;25:1320-3. [PubMed ID: 12392087].

  • 22.

    Zou YP, Lu YH, Wei DZ. Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in-vitro.J. Agr. Food Chem. 2004;52:5032-9. [PubMed ID: 15291471].

  • 23.

    Silva BA, Ferreres F, Malva JO, Dias ACP. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts. Food Chem. 2005;90:157-67.

  • 24.

    Wojdylo A, Oszmianski J, Czemerys R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007;105:940-9.

  • 25.

    Kizil G, Kizil M, Yavuz M, Emen S, Hakimoglu F. Antioxidant activities of ethanol extracts of Hypericum triquetrifolium and Hypericum scabroides. Pharm. Biol. 2008;46:231-42.

  • 26.

    Del Monte D, De Martino L, Marandino A, Fratianni F, Nazzaro F, De Feo V. Phenolic content, antimicrobial and antioxidant activities of Hypericum perfoliatum L. Ind. Crops Prod. 2015;74:342-7.

  • 27.

    Savikin K, Dobric S, Tadic V, Zdunic G. Antiinflammatory activity of ethanol extracts of Hypericum perforatum L., H-barbatum Jacq., H-hirsutum L., H-richeri Vill. and H-androsaemum L. in rats. Phytother. Res. 2007;21:176-80. [PubMed ID: 17143926].

  • 28.

    Perazzo FF, Lima LM, Padilha MD, Rocha LM, Sousa PJC, Carvalho JCT. Anti-inflammatory and analgesic activities of Hypericum brasiliense (Willd) standardized extract. Rev. Bras. Farmacogn. 2008;18:320-5.

  • 29.

    Tedeschi E, Menegazzi M, Margotto D, Suzuki H, Forstermann U, Kleinert H. Anti-inflammatory actions of St John’s wort: Inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1 alpha (STAT-1 alpha) activation. J. Pharmacol. Exp. Ther. 2003;307:254-61. [PubMed ID: 12954801].

  • 30.

    Turini ME, DuBois RN. Cyclooxygenase-2: A therapeutic target. Annu. Rev. Med. 2002;53:35-57. [PubMed ID: 11818462].

  • 31.

    Arruda M, Rainha N, Barreto M, Lima E, Baptista J. Acetylcholinesterase inhibition properties of Hypericum foliosum Aiton. Planta Med. 2010;76:1211.

  • 32.

    Hernandez MF, Fale PLV, Araujo MEM, Serralheiro MLM. Acetylcholinesterase inhibition and antioxidant activity of the water extracts of several Hypericum species. Food Chem. 2010;120:1076-82.

  • 33.

    Wszelaki N, Kuciun A, Kiss AK. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity. Acta Pharm. 2010;60:119-28. [PubMed ID: 20228046].

  • 34.

    Altun ML, Yilmaz BS, Orhan IE, Citoglu GS. Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L (St. John’s wort).Ind. Crops Prod. 2013;43:87-92.

  • 35.

    Zheleva-Dimitrova D, Nedialkov P, Momekov G. Benzophenones from Hypericum elegans with antioxidant and acetylcholinesterase inhibitory potential. Pharmacogn. Mag. 2013;9:1-5. [PubMed ID: 23661985].

  • 36.

    Conforti F, Loizzo MR, Statti AG, Menichini F. Cytotoxic activity of antioxidant constituents from Hypericum triquetrifolium Turra. Nat. Prod. Res. 2007;21:42-6. [PubMed ID: 17365688].

  • 37.

    Peron AP, Mariucci RG, de Almeida IV, Dusman E, Mantovani MS, Vicentini VEP. Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of a natural antidepressant, Hypericum perforatum L (St John’s wort), on vegetal and animal test systems. BMC Complement. Altern. Med. 2013;13:97.

  • 38.

    Trovato A, Raneri E, Kouladis M, Tzakou O, Taviano MF, Galati EM. Anti-inflammatory and analgesic activity of Hypericum empetrifolium Willd. (Guttiferae) Farmaco. 2001;56:455-7. [PubMed ID: 11482777].

  • 39.

    Rabanal RM, Bonkanka CX, Hernandez-Perez M, Sanchez-Mateo CC. Analgesic and topical anti-inflammatory activity of Hypericumcanariense L and Hypericumglandulosum Ait. J. Ethnopharmacol. 2005;96:591-6. [PubMed ID: 15619583].

  • 40.

    Ozkan EE, Ozsoy N, Ozhan G, Celik BO, Mat A. Chemical composition and biological activities of Hypericum pamphylicum. Ind. Crops Prod. 2013;50:182-9.

  • 41.

    Slinkard K, Singleton VL. Total phenol analysis: Automation and comparison with manual methods. Am. J. Enology Vitic. 1977;28:49-55.

  • 42.

    Duh PD, Tu YY, Yen GC. Antioxidant activity of water extract of Harng Jyur (Chrysanthemum morifolium Ramat). LWT-Food Sci. Technol. 1999;32:269-77.

  • 43.

    Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-10. [PubMed ID: 672633].

  • 44.

    Brandwilliams W, Cuvelier ME, Berset C. Use of a Free-Radical Method to Evaluate Antioxidant Activity. LWT-Food Sci. Technol. 1995;28:25-30.

  • 45.

    Nishikimi M, Appaji N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 1972;46:849-54. [PubMed ID: 4400444].

  • 46.

    Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of ‘’antioxidant power’’: The FRAP assay. Anal. Biochem. 1996;239:70-6. [PubMed ID: 8660627].

  • 47.

    Ellman GL, Courtney KD, Andres VJr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88-95. [PubMed ID: 13726518].

  • 48.

    Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55-63. [PubMed ID: 6606682].

  • 49.

    Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR. Feasibility of drug screening with panels of human-tumor cell-lines using a microculture tetrazolium assay. Cancer Res. 1988;48:589-601. [PubMed ID: 3335022].

  • 50.

    Mahavorasirikul W, Viyanant V, Chaijaroenkul W, Itharat A, Na-Bangchang K. Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in-vitro. BMC Complement. Altern. Med. 2010;10:55. [PubMed ID: 20920194].

  • 51.

    Silva BA, Malva JO, Dias ACP. St John’s Wort (Hypericum perforatum) extracts and isolated phenolic compounds are effective antioxidants in several in-vitro models of oxidative stress. Food Chem. 2008;110:611-9.

  • 52.

    Ozturk N, Tuncel M, Potoglu-Erkara I. Phenolic compounds and antioxidant activities of some Hypericum species: A comparative study with H. perforatum.Pharm. Biol. 2009;47:120-7.

  • 53.

    Zheleva-Dimitrova D, Nedialkov P, Kitanov G. Radical scavenging and antioxidant activities of methanolic extracts from Hypericum species growing in Bulgaria. Pharmacogn. Mag. 2010;6:74-8. [PubMed ID: 20668569].

  • 54.

    Couladis M, Badisa RB, Baziou P, Chaudhuri SK, Pilarinou E, Verykokidou E, Harvala C. Antioxidant and cytotoxic activities of Hypericum sp on brine shrimps and human cancer cell lines. Phytother. Res. 2002;16:719-22. [PubMed ID: 12458472].

  • 55.

    Baris D, Kizil M, Aytekin C, Kizil G, Yavuz M, Ceken B, Ertekin AS. In-vitro antimicrobial and antioxidant activity of ethanol extract of three Hypericum and three Achillea species from Turkey. Int. J. Food Prop. 2011;14:339-55.

  • 56.

    Chen CL, Huang CH, Sung JM. Antioxidants in aerial parts of Hypericum sampsonii, Hypericum japonicum and Hypericum perforatum. Int. J. Food. Sci. Tech. 2009;44:2249-55.

  • 57.

    Ferreira A, Proenca C, Serralheiro MLM, Araujo MEM. The in-vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J. Ethnopharmacol. 2006;108:31-7. [PubMed ID: 16737790].

  • 58.

    Calixto JB, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin Part I Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappa B). Planta Med. 2003;69:973-83. [PubMed ID: 14735432].

  • 59.

    Huang N. Identification of anti-inflammatory constituents in Hypericum species and unveiling the underlying mechanism in LPS-stimulated mouse macrophages and H1N1 influenza virus infected BALB/c mouse. Ames: Iowa State University; 2011. 69 p.

  • 60.

    Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J. Nutr. 2008;138:2309-15. [PubMed ID: 19022950].

  • 61.

    Hwang SJ, Kim YW, Park Y, Lee HJ, Kim KW. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 2647 cells. Inflamm. Res. 2014;63:81-90. [PubMed ID: 24127072].

  • 62.

    Azza EM, Yieldez B, Mahmoud K, Abdullatif M. Chlorogenic acid as potential anti-inflammatory analgesic agent: An investigation of the possible role of nitrogen-based radicals in rats. IJPTS. 2011;1:24-33.

  • 63.

    Roscetti G, Franzese O, Comandini A, Bonmassar E. Cytotoxic activity of Hypericum perforatum L on K562 erythroleukemic cells: Differential effects between methanolic extract and hypericin. Phytother. Res. 2004;18:66-72. [PubMed ID: 14750204].

  • 64.

    Moon HI. Antiplasmodial and cytotoxic activity of phloroglucinol derivatives from Hypericum erectum Thunb. Phytother. Res. 2010;24:941-4. [PubMed ID: 20127665].